Seizure and Interictal Electroencephalographic (EEG) Changes with Cannabinoid Concentrate Use.


Journal

The American journal of case reports
ISSN: 1941-5923
Titre abrégé: Am J Case Rep
Pays: United States
ID NLM: 101489566

Informations de publication

Date de publication:
18 Apr 2021
Historique:
entrez: 18 4 2021
pubmed: 19 4 2021
medline: 22 4 2021
Statut: epublish

Résumé

BACKGROUND The electroencephalographic (EEG) findings associated with tetrahydrocannabinol (THC) use, particularly in concentrated form, are not well-described, despite the current widespread availability of these products. There is a lack of prior research describing the EEG findings in adolescent cannabis users, and the effects of THC on the seizure threshold have been variably reported. CASE REPORT A 17-year-old girl with no prior history of seizures or known seizure risk factors presented to an Emergency Department with acutely abnormal behavior in the setting of daily vaping of highly concentrated THC marijuana ("wax"). On admission, she had a witnessed generalized tonic-clonic seizure. Urine toxicology was positive for THC, and an extensive evaluation for other etiologies of her encephalopathy was unrevealing. Extended EEG on admission showed mild diffuse background slowing with occasional bifronto-centrally predominant sharp and spike wave discharges. Seven days later, without interim antiseizure medications, a repeat extended EEG showed resolution of the previously seen interictal findings. CONCLUSIONS The clinical and EEG findings were temporally associated with the patient's use of concentrated THC and may represent a constellation of symptoms of a THC wax toxidrome. In this case, THC was associated with lowering the seizure threshold and triggering a provoked seizure in an adolescent with no prior evidence of seizure tendency. This case also suggests the possibility of THC concentrate itself generating epileptiform discharges, as has previously been described with synthetic cannabinoid use.

Identifiants

pubmed: 33866321
pii: 931360
doi: 10.12659/AJCR.931360
pmc: PMC8063765
doi:

Substances chimiques

Cannabinoids 0
Dronabinol 7J8897W37S

Types de publication

Case Reports Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e931360

Références

Drugs Today (Barc). 2003 Jul;39(7):551-7
pubmed: 12973403
Curr Pharm Des. 2014;20(13):2186-93
pubmed: 23829363
Epilepsia. 2001 Oct;42(10):1266-72
pubmed: 11737161
Behav Neurosci. 2009 Aug;123(4):894-904
pubmed: 19634950
Yakugaku Zasshi. 2019;139(5):693-697
pubmed: 31061337
Neuropsychopharmacology. 2013 Nov;38(12):2338-47
pubmed: 23822952
Biol Psychiatry. 2016 Apr 1;79(7):568-77
pubmed: 26850792
Nat Rev Neurosci. 2015 May;16(5):264-77
pubmed: 25891509
Epilepsy Behav. 2020 Mar;104(Pt A):106901
pubmed: 31958643
Neurohospitalist. 2011 Oct;1(4):182-6
pubmed: 23983854

Auteurs

Madeline D Kahan (MD)

Department of Neurology, University of California San Francisco (UCSF), San Francisco, CA, USA.

Andrew Breithaupt (A)

Department of Neurology, University of California San Francisco (UCSF), San Francisco, CA, USA.

Kendall Nash (K)

Department of Neurology, University of California San Francisco (UCSF), San Francisco, CA, USA.

Adam L Numis (AL)

Department of Neurology, University of California San Francisco (UCSF), San Francisco, CA, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH